Beauty Health Co

For the period ended Dec 31, 2023. Filed Mar 12, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 12, 2024

SKIN$15.94-4.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Comprehensive Income (Loss

(in thousands, except for share and per share amounts)

	Year Ended December 31,
	2023	2022	2021
Net sales	$397,991	$365,876	$260,086
Cost of sales	242,878	117,097	81,548
Gross profit	155,113	248,779	178,538
Operating expenses:
Selling and marketing	144,496	160,076	111,583
Research and development	10,102	8,444	8,195
General and administrative	131,432	106,100	98,688
Total operating expenses	286,030	274,620	218,466
Loss from operations	(130,917)	(25,841)	(39,928)
Interest expense	13,649	13,392	11,777
Interest income	(23,173)	(9,175)	(39)
Other (income) expense, net	(5,200)	1,650	4,489
Change in fair value of warrant liabilities	(11,919)	(78,343)	277,315
Change in fair value of earn-out shares	—	—	47,100
Foreign currency transaction (gain) loss, net	(2,385)	1,296	69
(Loss) income before provision for income taxes	(101,889)	45,339	(380,639)
Income tax (benefit) expense	(1,773)	1,115	(1,875)
Net (loss) income	(100,116)	44,224	(378,764)
Comprehensive (loss) income, net of tax:
Foreign currency translation adjustments	1,494	(3,273)	(1,499)
Comprehensive (loss) income	$(98,622)	$40,951	$(380,263)
Net (loss) income per share
Basic	$(0.76)	$0.30	$(3.71)
Diluted	$(0.76)	$(0.23)	$(3.71)
Weighted average common shares outstanding
Basic	131,680,605	147,554,090	102,114,949
Diluted	131,680,605	148,506,312	102,114,949

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.